AI-powered healthcare devices are on the rise as innovators strive to harness the powers of artificial intelligence to enhance the precision, efficiency, and convenience of monitoring, treatment, and preventative care. AEYE Health and Optomed have recently announced the launch of Aurora AEYE, a groundbreaking portable, AI-powered healthcare device designed for diabetic retinopathy screening. This innovative product, which will debut at the American Diabetes Association's 84th Scientific Sessions in Orlando, is the first FDA-cleared portable solution that provides instant diagnostic results without needing human interpretation.
Aurora AEYE requires just one image per eye and delivers immediate results on the camera screen, making it suitable for use in various settings. his device aims to enhance the accessibility and efficiency of diabetic retinopathy screening, generates diagnostic reports for healthcare providers, and streamlines insurance reporting.